Gilead Sciences Inc.: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-07-05
Other years: 2026 vs 2025 · 2025 vs 2024
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

2
New Risks
0
Removed
5
Modified
17
Unchanged
🟢 New in Current Filing Climate change and related natural disasters, as well as legal, regulatory, or market measures to address climate change, can negatively affect our business and operations. 🔒
🟢 New in Current Filing The failure to successfully implement or upgrade enterprise resource planning and other information systems could adversely impact our business and results of operations. 🔒
🟡 Modified Information system service interruptions or breaches, including significant cybersecurity incidents, could give rise to legal liability and regulatory action under data protection and privacy laws and adversely affect our business and operations. 🔒
🟡 Modified We face risks in our clinical trials, including the potential for unfavorable results, delays in anticipated timelines and disruption. 🔒
🟡 Modified We face risks associated with our global operations. 🔒
🟡 Modified We face potentially significant liability and increased expenses from litigation and government investigations relating to our products and operations. 🔒
🟡 Modified Certain of our products subject us to additional or heightened risks. 🔒
7 changes in this historical filing

Historical year-over-year comparisons (2024 vs 2023 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →